Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer. [electronic resource] by
- Köstek, O
- Demircan, N C
- Gökyer, A
- Küçükarda, A
- Sunal, B S
- Hacıoğlu, M B
- Eslame, H
- Solak, S
- Yılmaz, E
- Uzunoğlu, S
- Tunçbilek, N
- Çiçin, I
- Erdoğan, B
Producer: 20191226
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 21
Availability: No items available.
|